Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-120033

Chief Financial Officer acquired 599,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gabay Avraham Chief Financial Officer 2026-11-12 Grant or award +357,000 1,218,076 D
Gabay Avraham Chief Financial Officer 2026-11-12 Grant or award +242,000 1,460,076 D
Loading xslF345X06/ownership.xml…